{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:38:38Z","timestamp":1784741918562,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Community Ment Health J"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10597-018-0349-2","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:18:23Z","timestamp":1540264703000},"page":"819-824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0106-3073","authenticated-orcid":false,"given":"Mar\u00eda-Jos\u00e9","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Roura-Poch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f9ria","family":"Riera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep-Manel","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Escot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"issue":"5","key":"349_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/11587810-000000000-00000","volume":"25","author":"TR Barnes","year":"2011","unstructured":"Barnes, T. R., & Paton, C. (2011). Antipsychotic polypharmacy in schizophrenia: Benefits and risks. CNS Drugs, 25(5), 383\u2013399.","journal-title":"CNS Drugs"},{"key":"349_CR2","unstructured":"Behavioural Health Planning Council. (2003). Assertive Community Treatment workbook. Retrieved from \n                    http:\/\/www.wvmhpc.org\/docs\/ACT_workbook.pdf\n                    \n                  ."},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/bmj.39251.599259.55","volume":"335","author":"T Burns","year":"2007","unstructured":"Burns, T., Catty, J., Dash, M., Roberts, C., Lockwood, A., & Marshall, M. (2007). Use of intensive case management to reduce time in hospital in people with severe mental illness: Systematic review and meta-regression. BMJ, 335, 336.","journal-title":"BMJ"},{"issue":"3","key":"349_CR4","first-page":"e2301","volume":"2","author":"Canadian Agency for Drugs and Technologies in Health","year":"2012","unstructured":"Canadian Agency for Drugs and Technologies in Health. (2012). Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: Systematic review. CADTH Technology Overviews, 2(3), e2301.","journal-title":"CADTH Technology Overviews"},{"key":"349_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a006928","volume":"28","author":"R Clark","year":"2002","unstructured":"Clark, R., Bartels, S., Mellman, T., & Peacock, W. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 28, 75\u201384.","journal-title":"Schizophrenia Bulletin"},{"key":"349_CR6","volume-title":"Pla de serveis individualitzats (PSI)","author":"Consell Assessor sobre Assist\u00e8ncia Psiqui\u00e0trica i Salut Mental","year":"2003","unstructured":"Consell Assessor sobre Assist\u00e8ncia Psiqui\u00e0trica i Salut Mental (2003). Pla de serveis individualitzats (PSI). Barcelona: Servei Catal\u00e0 de la Salut."},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.schres.2015.05.038","volume":"166","author":"RJ Constantine","year":"2015","unstructured":"Constantine, R. J., Andel, R., McPherson, M., & Tandon, R. (2015). The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial. Schizophrenia Research, 166, 194\u2013200.","journal-title":"Schizophrenia Research"},{"issue":"4","key":"349_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/schbul\/sbx061","volume":"43","author":"M Dieterich","year":"2017","unstructured":"Dieterich, M., Irving, C. B., Bergman, H., Khokhar, M. A., Park, B., & Marshall, M. (2017). Intensive case management for severe mental illness. Schizophrenia Bulletin, 43(4), 698\u2013700.","journal-title":"Schizophrenia Bulletin"},{"issue":"9","key":"349_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.euroneuro.2013.03.001","volume":"23","author":"M Dold","year":"2013","unstructured":"Dold, M., Li, C., Gillies, D., & Leucht, S. (2013). Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and Cochrane review of randomized controlled trials. European Neuropsychopharmacology, 23(9), 1023\u20131033.","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"349_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner, D. M., Murphy, A. L., O\u2019Donnell, H., Centorrino, F., & Baldessarini, R. J. (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry, 167(6), 686\u2013693.","journal-title":"American Journal of Psychiatry"},{"key":"349_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/oxfordjournals.schbul.a033447","volume":"26","author":"P Garety","year":"2000","unstructured":"Garety, P., Fowler, D., & Kuipers, E. (2000). Cognitive-behavioral therapy for medication-resistant symptoms. Schizophrenia Bulletin, 26, 73\u201386.","journal-title":"Schizophrenia Bulletin"},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1192\/bjp.149.2.137","volume":"149","author":"J Hoult","year":"1986","unstructured":"Hoult, J. (1986). Community care of the acutely mentally ill. The British Journal of Psychiatry, 149, 137\u2013144.","journal-title":"The British Journal of Psychiatry"},{"key":"349_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/bmj.38773.518322.7C","volume":"332","author":"H Killaspy","year":"2006","unstructured":"Killaspy, H., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., Pilling, S., et al. (2006). The REACT study: Randomised evaluation of assertive community treatment in North London. British Medical Journal, 332, 815\u2013820.","journal-title":"British Medical Journal"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-244X-9-24","volume":"9","author":"RA Kroken","year":"2009","unstructured":"Kroken, R. A., Johnsen, E., Ruud, T., Wentzel-Larsen, T., & J\u00f8rgensen, H. A. (2009). Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry, 9, 24.","journal-title":"BMC Psychiatry"},{"issue":"2 Suppl","key":"349_CR15","first-page":"1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman, A. F., Lieberman, J. A., Dixon, L. B., McGlashan, T. H., Miller, A. L., Perkins, D. O., et al. (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry, 161(2 Suppl), 1\u201356.","journal-title":"American Journal of Psychiatry"},{"key":"349_CR16","first-page":"CD000050","volume":"2","author":"M Marshall","year":"2000","unstructured":"Marshall, M., Gray, A., Lockwood, A., & Green, R. (2000). Case management for people with severe mental disorders. Cochrane Database of Systematic Reviews, 2, CD000050.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"349_CR17","volume-title":"Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care","author":"National Collaborating Centre for Mental Health","year":"2009","unstructured":"National Collaborating Centre for Mental Health. (2009). Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. Leicester: British Psychological Society."},{"key":"349_CR18","volume-title":"High dose antipsychotic therapy guideline","author":"National Health Service Foundation Trust","year":"2012","unstructured":"National Health Service Foundation Trust. (2012). High dose antipsychotic therapy guideline. London: Humber NHS."},{"key":"349_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1600-0447.2010.01576.x","volume":"122","author":"J Nielsen","year":"2010","unstructured":"Nielsen, J., Le Quach, P., Emborg, C., Foldager, L., & Correll, C. U. (2010). 10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatrica Scandinavica, 122, 356\u2013366.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"349_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/01.pra.0000308492.93003.db","volume":"14","author":"S Rathod","year":"2008","unstructured":"Rathod, S., Kingdon, D., Weiden, P., & Turkington, D. (2008). Cognitive-behavioral therapy for medication-resistant schizophrenia: A review. Journal of Psychiatric Practice, 14, 1022\u20131033.","journal-title":"Journal of Psychiatric Practice"},{"issue":"3","key":"349_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360(3), 225\u2013235.","journal-title":"New England Journal of Medicine"},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1745017901107010001","volume":"7","author":"N Satake","year":"2011","unstructured":"Satake, N., Hazama, K., Sono, T., Takashashi, M., & Ito, J. (2011). Changes in antipsychotic medication in clients of assertive community treatment in Japan: A one-year follow up. Clinical Practice and Epidemiology in Mental Health, 7, 1\u20133.","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"issue":"4","key":"349_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archpsyc.1980.01780170034003","volume":"37","author":"LI Stein","year":"1980","unstructured":"Stein, L. I., & Test, M. A. (1980). Alternative to mental hospital treatment. Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry, 37(4), 392\u2013397.","journal-title":"Archives of General Psychiatry"},{"key":"349_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1600-0447.2007.01021.x","volume":"116","author":"S Sytema","year":"2007","unstructured":"Sytema, S., Wunderink, L., Bloemers, W., Roorda, L., & Wiersma, D. (2007). Assertive community treatment in the Netherlands: A randomized controlled trial. Acta Psychiatrica Scandinavica, 116, 105\u2013112.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"349_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/schbul\/sbu164","volume":"41","author":"M Torniainen","year":"2015","unstructured":"Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bj\u00f6rkenstam, C., Suvisaari, J., Alexanderson, K., et al. (2015). Antipsychotic treatment and mortality in schizophrenia. Schizophrenia Bulletin, 41(3), 656\u2013663.","journal-title":"Schizophrenia Bulletin"},{"key":"349_CR26","volume-title":"Medimecum. Gu\u00eda de terapia farmacol\u00f3gica","author":"LF Villa Alcazar","year":"2011","unstructured":"Villa Alcazar, L. F., & Esteban Calvo, C. (2011). Medimecum. Gu\u00eda de terapia farmacol\u00f3gica. Madrid: Adis."},{"key":"349_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu016","volume":"18","author":"Y Yamanouchi","year":"2015","unstructured":"Yamanouchi, Y., Sukegawa, T., Inagaki, A., Inada, T., Yoshio, T., Yoshimura, R., et al. (2015). Evaluation of the individual safe correction of antipsychotic agent polypharmacy in japanese patients with chronic schizophrenia. Validation of safe corrections for antipsychotic polypharmacy and the high-dose method. International Journal of Neuropsychopharmacology, 18, 1\u20138.","journal-title":"International Journal of Neuropsychopharmacology"}],"container-title":["Community Mental Health Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10597-018-0349-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10597-018-0349-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10597-018-0349-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T11:15:38Z","timestamp":1571829338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10597-018-0349-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s10597-018-0349-2","relation":{},"ISSN":["0010-3853","1573-2789"],"issn-type":[{"value":"0010-3853","type":"print"},{"value":"1573-2789","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}